Fig. 1From: Factors associated with 1-year visual response following intravitreal bevacizumab treatment for diabetic macular edema: a retrospective single center studyProportion of eyes stratified by visual acuity level at baseline, week 12, and month 12 following intravitreal bevacizumab injections for visual impairment from center-involved diabetic macular edemaBack to article page